Rhizome has unveiled Rhizome OS-1, a semi-autonomous operating system using AI agents to facilitate small molecule drug discovery in oncology. This system leverages advanced machine learning techniques to generate novel molecular structures with high structural diversity and accurate binding affinity predictions, marking a significant advancement for early-stage drug development by enabling rapid and adaptive design processes.
Read the full article at arXiv cs.LG (ML)
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

![[AINews] The Unreasonable Effectiveness of Closing the Loop](/_next/image?url=https%3A%2F%2Fmedia.nemati.ai%2Fmedia%2Fblog%2Fimages%2Farticles%2F600e22851bc7453b.webp&w=3840&q=75)



